ClinicalTrials.Veeva

Menu

Stress Management to Support Women's Health

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Hypertension
Cardiovascular Diseases
Stress

Treatments

Behavioral: Usual Care
Behavioral: MBCT-T

Study type

Interventional

Funder types

Other

Identifiers

NCT03223545
17-00725

Details and patient eligibility

About

The purpose of this study is to evaluate a mindfulness-based cognitive therapy intervention delivered over the phone (MBCT-T) for women with prehypertension. MBCT-T is an evidence-based program that teaches meditation practices and cognitive strategies to reduce stress and negative emotions. It targets psychosocial risk factors that disproportionately affect women, including rumination (i.e., negative thinking) and low social support. Investigators plan to translate the established MBCT-T program into Spanish, conduct focus groups to inform cultural adaptations that may be needed for Latina women, and run a pilot randomized controlled trial to test the feasibility, acceptability and effects of MBCT-T on blood pressure and perceived stress in diverse women with prehypertension.

Full description

Chronic stress is associated with the development of hypertension and cardiovascular disease. Reducing stress may be a useful prevention strategy for people at elevated risk of hypertension, including those with prehypertension. Women report different types of stress than men and may need tailored stress management programs.

Enrollment

106 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female
  • English- or Spanish-speaking
  • A current patient of NYU/Bellevue Hospital Center (BHC) for the NYU study site or San Ysidro Health Center (SYHC) for the UCSD study site
  • BP measurement in prehypertensive range (SBP 120-139 mmHg or DBP 80-89 mmHg) recorded in EHR within past 6 months AND BP in prehypertensive range at screening
  • Willing to provide informed consent and comply with all aspects of the protocol
  • Willing to be audio-taped

Exclusion criteria

  • Current use of antihypertensive medication
  • Clinically significant depressive symptoms (PHQ-8 ≥10)
  • Significant cognitive impairment, in the EHR or apparent during screening
  • History of current diagnosis of schizophrenia or other psychotic disorders
  • Current participation in another clinical trial

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

106 participants in 2 patient groups, including a placebo group

Mindfulness-based cognitive therapy delivered by telephone
Experimental group
Treatment:
Behavioral: MBCT-T
Usual Care (UC)
Placebo Comparator group
Treatment:
Behavioral: Usual Care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems